Share Agreements in the Pharmaceuticals Industry
198 Contracts & Agreements
- ACHILLION PHARMACEUTICALS INC (1 contract)
- Adamis Pharmaceuticals Corp (2)
- Akorn (2)
- ALIMERA SCIENCES INC (1)
- Amag Pharmaceuticals (1)
- AmeriCann, Inc. (1)
- Amneal Pharmaceuticals, Inc. (1)
- Amphastar Pharma (1)
- Ampio Pharmaceuticals, Inc. (1)
- Aralez Pharmaceuticals Inc. (7)
- ARIAD PHARMACEUTICALS INC (1)
- ATAI Life Sciences B.V. (1)
- AVADEL PHARMACEUTICALS PLC (1)
- Axsome Therapeutics, Inc. (1)
- Bausch Health Companies Inc. (1)
- Biohaven Ltd. (1)
- Biostar Pharmaceuticals, Inc. (3)
- CADENCE PHARMACEUTICALS INC (2)
- Canopy Growth Corp (2)
- Catalent Inc (8)
- CHINA PEDIATRIC PHARMACEUTICALS, INC. (1)
- China Pharmaceuticals Inc (1)
- China QinBa Pharmaceuticals, Inc. (1)
- Clever Leaves Holdings Inc. (3)
- Cocrystal Pharma, Inc. (1)
- COSMO VENTURES INC (1)
- Cronos Group Inc. (2)
- Cure Pharmaceutical Holding Corp. (1)
- Elanco Animal Health Inc (4)
- Eloxx Pharmaceuticals, Inc. (2)
- Evoke Pharma Inc (1)
- Evolus, Inc. (1)
- EYEGATE PHARMACEUTICALS INC (1)
- EyePoint Pharmaceuticals, Inc. (4)
- Foamix Pharmaceuticals Ltd. (2)
- GREEN HYGIENICS HOLDINGS INC. (1)
- Horizon Pharma plc (2)
- INNOVATE BIOPHARMACEUTICALS, INC. (2)
- IntelGenx Technologies Corp. (1)
- Item 9 Labs Corp. (1)
- Iterum Therapeutics plc (4)
- Jaguar Health, Inc. (2)
- Jazz Pharmaceuticals plc (5)
- JINZANGHUANG TIBET PHARMACEUTICALS, INC. (1)
- Johnson & Johnson (2)
- JUNIPER PHARMACEUTICALS INC (1)
- Kedem Pharmaceuticals Inc. (1)
- KOS PHARMACEUTICALS INC (1)
- Lexaria Bioscience Corp. (1)
- Lotus Pharmaceuticals, Inc. (2)
- Mallinckrodt (2)
- Menlo Therapeutics Inc. (1)
- Merck (1)
- MICROCHANNEL TECHNOLOGIES CORP (2)
- Milestone Pharmaceuticals Inc. (1)
- Mind Medicine (MindMed) Inc. (4)
- MJ Pharmaceuticals Inc. (1)
- NEKTAR THERAPEUTICS (2)
- Neuralstem, Inc. (1)
- NEW RIVER PHARMACEUTICALS INC (1)
- NewBridge Global Ventures, Inc. (2)
- NovaBay Pharmaceuticals, Inc. (4)
- One World Pharma, Inc. (1)
- ONYX PHARMACEUTICALS INC (3)
- ORAMED PHARMACEUTICALS INC. (1)
- Osmotica Pharmaceuticals plc (5)
- PEAK PHARMACEUTICALS, INC. (2)
- PENWEST PHARMACEUTICALS CO (1)
- Perrigo (1)
- Pfizer (1)
- Pivot Pharmaceuticals Inc. (1)
- Processa Pharmaceuticals, Inc. (2)
- PROTECT PHARMACEUTICAL Corp (1)
- QUANTA INC (1)
- RELMADA THERAPEUTICS, INC. (1)
- resTORbio, Inc. (4)
- Roivant Sciences Ltd. (1)
- Royalty Pharma plc (2)
- Sagent Pharmaceuticals, Inc. (5)
- SCICLONE PHARMACEUTICALS INC (1)
- Stem Holdings, Inc. (1)
- Strongbridge Biopharma plc (1)
- Sucampo Pharmaceuticals, Inc. (3)
- TETRAPHASE PHARMACEUTICALS INC (1)
- Theravance Biopharma, Inc. (5)
- TIBET PHARMACEUTICALS, INC. (7)
- Tilray, Inc. (1)
- TITAN PHARMACEUTICALS INC (1)
- Trevi Therapeutics, Inc. (1)
- Tribute Pharmaceuticals Canada Inc. (3)
- Trulieve Cannabis Corp. (2)
- Urovant Sciences Ltd. (1)
- Ventyx Biosciences, Inc. (2)
- VION PHARMACEUTICALS INC (2)
- Vitality Biopharma, Inc. (4)
- Wave Life Sciences Ltd. (13)
- Zoetis (1)
- Zomedica Pharmaceuticals Corp. (1)
- Form of Mind Medicine (MindMed) Inc. Common Share Certificate (Mind Medicine (MindMed) Inc., Filed With SEC on February 28, 2024)
- Description of Share Capital (Jazz Pharmaceuticals plc, Filed With SEC on February 28, 2024)
- Share Purchase Deed, dated January 18, 2024, by and among the Company, Beckley Psytech Limited, and certain other persons set forth therein.1 (ATAI Life Sciences B.V., Filed With SEC on January 23, 2024)
- First Share Purchase and Transfer Agreement, dated October 17, 2023, by and among Northern Swan Deutschland Holdings, Inc., Cansativa GmbH and EIP Entrepreneurial Investment GmbH (Clever Leaves Holdings Inc., Filed With SEC on October 23, 2023)
- Form of Common Share Purchase and Sale Agreement (Roivant Sciences Ltd., Filed With SEC on September 29, 2023)
- Share Purchase Agreement, dated May 19, 2023, by and among Canopy USA, LLC and Huneeus 2017 Irrevocable Trust (Canopy Growth Corp, Filed With SEC on August 9, 2023)
- Wave Life Sciences Ltd. 2019 Employee Share Purchase Plan, as amended (Wave Life Sciences Ltd., Filed With SEC on August 7, 2023)
- Directors Deferred Share Unit Plan, amended as of June 8, 2023 (Mind Medicine (MindMed) Inc., Filed With SEC on August 3, 2023)
- Share Lending Agreement, dated May 25, 2023, between Tilray Brands, Inc. and Jefferies Capital Services, LLC (Tilray, Inc., Filed With SEC on May 31, 2023)
- Form of Amendment to Share Option (Biohaven Ltd., Filed With SEC on May 12, 2023)
- Description of Share Capital (Jazz Pharmaceuticals plc, Filed With SEC on March 1, 2023)
- Floating Share Arrangement Agreement dated October 24, 2022 by and among Canopy Growth Corporation, Canopy USA, LLC and Acreage Holdings, Inc (Canopy Growth Corp, Filed With SEC on October 26, 2022)
- Share Option Cancellation Agreement, dated July 7, 2022, between Iterum Therapeutics plc and Judith M. Matthews (Iterum Therapeutics plc, Filed With SEC on August 12, 2022)
- Share Option Cancellation Agreement, dated July 7, 2022, between Iterum Therapeutics plc and Corey N. Fishman (Iterum Therapeutics plc, Filed With SEC on August 12, 2022)
- Directors Deferred Share Unit Plan (Mind Medicine (MindMed) Inc., Filed With SEC on August 11, 2022)
- Share Purchase Agreement dated May 18, 2022 (Item 9 Labs Corp., Filed With SEC on May 24, 2022)
- Share Purchase Agreement dated May 11, 2022, by and among Daedalus Ecosciences, the Company, Range Environmental Resources, Range Natural Resources, Jeremy Starks and Joshua... (Vitality Biopharma, Inc., Filed With SEC on May 13, 2022)
- RVL Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan (Osmotica Pharmaceuticals plc, Filed With SEC on March 30, 2022)
- Form of Mind Medicine (MindMed) Inc. Common Share Certificate (Mind Medicine (MindMed) Inc., Filed With SEC on March 28, 2022)
- Share Purchase Agreement, dated November 2, 2021, by and among Puniska Healthcare Pvt. Ltd. and Amneal Pharmaceuticals Private Limited (Amneal Pharmaceuticals, Inc., Filed With SEC on March 1, 2022)
- Description of Share Capital (Jazz Pharmaceuticals plc, Filed With SEC on March 1, 2022)
- Form of Inducement Restricted Share Unit Agreement (Wave Life Sciences Ltd., Filed With SEC on November 10, 2021)
- Form of Restricted Share Unit Agreement for UK Participants under the 2021 Equity Plan, effective as of August 10, 2021 (Wave Life Sciences Ltd., Filed With SEC on November 10, 2021)
- Form of Non-qualified Share Option Agreement for UK Participants under the 2021 Equity Plan, effective as of August 10, 2021 (Wave Life Sciences Ltd., Filed With SEC on November 10, 2021)
- Form of Restricted Share Unit Agreement under the 2021 Equity Plan, effective as of August 10, 2021 (Wave Life Sciences Ltd., Filed With SEC on November 10, 2021)
- Form of Non-qualified Share Option Agreement under the 2021 Equity Plan, effective as August 10, 2021 (Wave Life Sciences Ltd., Filed With SEC on November 10, 2021)
- Share Subscription Agreement dated October 1, 2021, between Osmotica Pharmaceuticals plc and Athyrium Opportunities IV Acquisition LP (Osmotica Pharmaceuticals plc, Filed With SEC on October 6, 2021)
- Share Purchase Agreement, dated as of February 26, 2021, by and among the Registrant, Oppilan Pharma Ltd. and certain of its Securityholders (Ventyx Biosciences, Inc., Filed With SEC on September 29, 2021)
- Share Purchase Agreement, dated as of February 26, 2021, by and among the Registrant, Zomagen Biosciences Ltd. and certain of its Securityholders (Ventyx Biosciences, Inc., Filed With SEC on September 29, 2021)
- Restricted Share Unit Award Agreement dated as of September 15, 2021 by and between Trulieve Cannabis Corp. and Jason Pernell (Trulieve Cannabis Corp., Filed With SEC on September 17, 2021)
- Restricted Share Unit Award Agreement dated as of September 15, 2021 by and between Trulieve Cannabis Corp. and Kim Rivers (Trulieve Cannabis Corp., Filed With SEC on September 17, 2021)
- Share Purchase Agreement by and between Amphastar Pharmaceuticals, Inc., Nanjing Zhongpan Enterprise Management Consulting Center (LLP), Nanjing Zhanrun Enterprise Management... (Amphastar Pharma, Filed With SEC on August 9, 2021)
- Amendment to Share Exchange (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on June 11, 2021)
- Specimen Common Share Certificate of Clever Leaves Holdings Inc (Clever Leaves Holdings Inc., Filed With SEC on May 17, 2021)
- Share Award Letter dated February 17, 2021 issued by Iterum Therapeutics plc to Dr. Michael Dunne and accepted by Dr. Michael Dunne on February 21, 2021 (Iterum Therapeutics plc, Filed With SEC on May 14, 2021)
- Share Issuance Agreement, dated February 18, 2021, by and between Evolus Inc. and Medytox, Inc (Evolus, Inc., Filed With SEC on May 12, 2021)
- Share Purchase Agreement by and between Ocumension Therapeutics and Alimera Sciences, Inc., dated as of April 14, 2021 (ALIMERA SCIENCES INC, Filed With SEC on April 14, 2021)
- Description of Share Capital (Jazz Pharmaceuticals plc, Filed With SEC on February 23, 2021)
- First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (EyePoint Pharmaceuticals, Inc., Filed With SEC on February 3, 2021)
- Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (EyePoint Pharmaceuticals, Inc., Filed With SEC on January 4, 2021)